Abstract
Tuberculostatics are crucial drugs to for life expectancy, mainly to HIV-positive patients. Several reasons justify the need for new antimycobacterial, including high morbilitiy and mortality related to tuberculosis. The resurgence of multidrug resistant (MDR-TB) and extensively drug resistant (XDR-TB), typical morphophysiological features of Mycobacterium tuberculosis, as well as phenoty…